Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients

Ge Wen-kai; Yang Ben; Zuo Wen-shu; Zheng Gang; Dai Ying-qi; Han Chao; Yang Li; Zheng Mei-zhu

首页> 外文期刊>Thoracic cancer. >Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients

【24h】

Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients

机译：核心针穿刺活检和新辅助化疗对乳腺癌患者激素受体，人表皮生长因子受体2和Ki-67的评价

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWe investigated the reliability of core needle biopsy (CNB) in evaluating the status of hormone receptor (HR), human epidermal growth factor receptor (HER)-2, and Ki-67 status, and the effect of neoadjuvant chemotherapy (NAC) on the expression of these immunohistochemical markers.

机译：背景我们研究了核心针穿刺活检（CNB）在评估激素受体（HR），人表皮生长因子受体（HER）-2和Ki-67状况以及新辅助化疗（NAC）对其影响方面的可靠性这些免疫组织化学标记的表达。

著录项

来源
《Thoracic cancer.》 |2015年第1期|共6页
作者
Ge Wen-kai; Yang Ben; Zuo Wen-shu; Zheng Gang; Dai Ying-qi; Han Chao; Yang Li; Zheng Mei-zhu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Biological markers; breast adenocarcinoma; core needle biopsy; neoadjuvant chemotherapy;

机译：生物学指标;乳腺癌;腺针活检;新辅助化疗;

相似文献

外文文献
中文文献
专利

1. Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients [J] . Ge Wen-kai, Yang Ben, Zuo Wen-shu, Thoracic cancer. . 2015,第1期

机译：核心针穿刺活检和新辅助化疗对乳腺癌患者激素受体，人表皮生长因子受体2和Ki-67的评价
2. The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial [J] . Dubsky Peter C., Singer Christian F., Egle Daniel, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第1期

机译：内舱的评分预测来自ABCSG-34试验的荷尔蒙受体阳性，人体表皮生长因子受体2阴性乳腺癌患者对新辅助化疗和新生内分泌治疗的反应
3. Gene expression profiling of breast cancers between high and low Ki-67 after short-term preoperative hormone therapy among hormone receptor-positive / human epidermal growth factor receptor 2-negative breast cancers with high Ki-67 [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：短期术前激素治疗乳腺癌患者乳腺癌在激素受体阳性/人体表皮生长因子受体2阴性乳腺癌中的短期术前激素治疗后乳腺癌的基因表达分析
4. Screening human epidermal growth factor receptor-2 inhibitors from natural products [C] . Liu Xiujie, Jia Shaohua, Dai Rongji, 2013 ICME International Conference on Complex Medical Engineering . 2013

机译：从天然产物中筛选人表皮生长因子受体2抑制剂
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Evaluation of hormone receptor human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients [O] . Wen-kai Ge, Ben Yang, Wen-shu Zuo, 2015

机译：激素针穿刺活检和新辅助化疗对乳腺癌患者激素受体人表皮生长因子受体2和Ki-67的评价
7. Analysis of discrepancies of core needle biopsy and surgical specimens for accurate evaluation of hormonal receptors and epidermal growth factor receptor 2 status of invasive breast cancer patients [O] . Ljiljana Tadic-Latinovic, Zivka Eri, Darko Jovic, 2016

机译：核心针活检和外科手术标本的差异分析，以准确评估激素受体和表皮生长因子受体2侵袭性乳腺癌患者的状态

Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients

摘要

著录项

相似文献

相关主题

期刊订阅